Business · 30/05/2014
FDA Classifies Dengue Virus Serological Reagents into Class II Special Controls
The FDA is classifying dengue virus serological reagents into class II special controls, which will provide a reasonable assurance of safety and effectiveness, in addition to general controls.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →